Kamada Ltd (KMDA) stock
KMDANasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.16+0.05 (+0.62%)
Close on Nov 17, 2026Market cap $470.72MP/E –Yield –
Kamada operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Kamada's operating cash flow for the twelve months ending Jun 30, 2026 was $35.76M, down 10.9% year over year. For fiscal 2025 it was $25.49M, down 46.4% from the year before. The highest annual figure on record is $47.59M in fiscal 2024.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $25.49M | -46.4% |
| FY2024 | Dec 31, 2024 | $47.59M | +1003.0% |
| FY2023 | Dec 31, 2023 | $4.32M | -84.9% |
| FY2022 | Dec 31, 2022 | $28.59M | – |
| FY2021 | Dec 31, 2021 | -$8.82M | -146.2% |
| FY2020 | Dec 31, 2020 | $19.11M | -30.7% |
| FY2019 | Dec 31, 2019 | $27.57M | +161.4% |
| FY2018 | Dec 31, 2018 | $10.55M | +192.3% |
| FY2017 | Dec 31, 2017 | $3.61M | +90.2% |
| FY2016 | Dec 31, 2016 | $1.90M | – |
| FY2015 | Dec 31, 2015 | -$13.98M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $18.07M | +125.3% |
| Q1 FY2026 | Mar 31, 2026 | -$291.00K | – |
| Q4 FY2025 | Dec 31, 2025 | $7.57M | -27.2% |
| Q3 FY2025 | Sep 30, 2025 | $10.42M | -53.1% |
| Q2 FY2025 | Jun 30, 2025 | $8.02M | -42.6% |
| Q1 FY2025 | Mar 31, 2025 | -$513.00K | -150.3% |
| Q4 FY2024 | Dec 31, 2024 | $10.40M | +135.8% |
| Q3 FY2024 | Sep 30, 2024 | $22.21M | +2311.8% |
| Q2 FY2024 | Jun 30, 2024 | $13.96M | +668.0% |
| Q1 FY2024 | Mar 31, 2024 | $1.02M | – |
| Q4 FY2023 | Dec 31, 2023 | $4.41M | -84.6% |
| Q3 FY2023 | Sep 30, 2023 | $921.00K | +16669.8% |
| Q2 FY2023 | Jun 30, 2023 | $1.82M | -83.3% |
| Q1 FY2023 | Mar 31, 2023 | -$2.85K | -100.1% |
| Q4 FY2022 | Dec 31, 2022 | $28.56M | – |
| Q3 FY2022 | Sep 30, 2022 | $5.49K | – |
| Q2 FY2022 | Jun 30, 2022 | $10.89M | – |
| Q1 FY2022 | Mar 31, 2022 | $5.47M | -57.1% |
| Q4 FY2021 | Dec 31, 2021 | -$4.97M | -308.6% |
| Q3 FY2021 | Sep 30, 2021 | -$2.67M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.28M | – |
| Q4 FY2020 | Dec 31, 2020 | $12.75M | – |
| Q3 FY2020 | Sep 30, 2020 | $2.38M | – |
See a number that looks wrong?